First Diagnostic Agent Approved to Image Tau Pathology in Patients Being Evaluated for Alzheimer Disease
Tauvid is indicated for use with positron emission tomography (PET) imaging of the brain.
Diagnostic Testing
Interim Data on Abbott ID NOW COVID-19 Rapid Test Performance Announced
An ongoing clinical study of the Abbott ID NOW™ COVID-19 rapid test shows strong agreement to lab-based molecular polymerase chain reaction (PCR) instruments.
FDA Authorizes At-Home Sample Collection Kit for Use With Multiple COVID-19 Diagnostics
The kit will be available only by prescription to individuals who have been screened using an online questionnaire that is reviewed by a healthcare provider.
ACR Issues Statement on Return of Routine Radiology Services
Comprehensive strategy for safe resumption should consider local COVID-19 statistics, PPE availability.
COVID-19 Diagnostics Update: First Antigen Test, New At-Home Saliva Collection Kit
The FDA has issued Emergency Use Authorization (EUA) to 2 new coronavirus disease 2019 (COVID-19) diagnostics.
FDA Goes After Unproven COVID-19 Antibody Tests
Companies selling tests will be required to submit data proving accuracy within next 10 days.
NIH Launches $500 Million Contest to Produce Best COVID-19 Test
Goal is to make millions of tests available to Americans each week by end of summer.
Rapid COVID-19 Test Can Produce False Negatives
Solutions known as ‘viral transport media’ should not be used for samples tested with the Abbott ID NOW device.
FDA Authorizes COVID-19 Testing Using Samples Collected by Patients at Home
The FDA has granted emergency use authorization (EUA) for the Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR Test that allows for testing of samples self-collected by patients at home using the Pixel by LabCorp COVID-19 Test home collection kit.
First Saliva Test for COVID-19 Approved by FDA
Patients spit into plastic tube and then give the tube back to health care worker for laboratory testing.
